• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与人类Fc结构域融合的新型嵌合人生长激素超级激动剂的设计与生产。

Design and production of a novel chimeric human growth hormone superagonist fused to human Fc domain.

作者信息

Mirbaha Samira, Rezaei Marzieh, Emamzadeh Rahman, Zarkesh Esfahani Sayyed Hamid

机构信息

Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, I.R. Iran.

Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

出版信息

Res Pharm Sci. 2022 Apr 18;17(3):284-293. doi: 10.4103/1735-5362.343082. eCollection 2022 Jun.

DOI:10.4103/1735-5362.343082
PMID:35531129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075020/
Abstract

BACKGROUND AND PURPOSE

Growth hormone (GH) has been known as a crucial metabolic hormone expressed at the pituitary and the other number of cells and tissues and responsible for body growth. Because of the short half-life of GH, daily subcutaneous injections were shown to be more effective for GH therapy. This represents a burden for patients. So, there is a strong effort from the industry to create a long-acting form of GH and lots of technologies like GH fusion proteins are used to increase GH half-life.

EXPERIMENTAL APPROACH

In this study, the Fc domain of human IgG1 with serine-glycine linkers was attached to the C-terminal of a GH superagonist molecular cloning. The presence of recombinant vector in host was confirmed by PCR. SDS-PAGE and western blot analysis showed the expression of recombinant proteins in the bacterial lysate. The binding ability to growth hormone receptors is determined by ELISA.

FINDINGS / RESULTS: Our results showed that the novel SupGH-Fc has a good binding affinity to its receptor in ELISA in comparison to standard GH, although it has a big size.

CONCLUSION AND IMPLICATIONS

Our data in this study clearly demonstrated the expression of the SupGH-Fc in a recombinant protein expression system. It is an introduction to the production of the new recombinant GH, which can bind to its receptor more effectively than commercial growth hormones and also might have a longer half-life.

摘要

背景与目的

生长激素(GH)是一种重要的代谢激素,由垂体以及其他多种细胞和组织分泌,负责身体生长。由于生长激素半衰期短,每日皮下注射对生长激素治疗更为有效。这给患者带来了负担。因此,业界大力致力于研发长效生长激素,许多技术如生长激素融合蛋白被用于延长生长激素的半衰期。

实验方法

在本研究中,将带有丝氨酸 - 甘氨酸连接子的人IgG1的Fc结构域连接到生长激素超级激动剂的C末端进行分子克隆。通过PCR确认宿主中重组载体的存在。SDS - PAGE和蛋白质印迹分析显示重组蛋白在细菌裂解物中的表达。通过ELISA测定与生长激素受体的结合能力。

研究结果

我们的结果表明,尽管新型SupGH - Fc体积较大,但在ELISA中与标准生长激素相比,它与其受体具有良好的结合亲和力。

结论与意义

我们在本研究中的数据清楚地证明了SupGH - Fc在重组蛋白表达系统中的表达。这为新型重组生长激素的生产奠定了基础,该重组生长激素与商业生长激素相比能更有效地与其受体结合,并且可能具有更长的半衰期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/a90698816605/RPS-17-284-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/4a0108827407/RPS-17-284-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/fc5448299a84/RPS-17-284-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/e0f989e255a0/RPS-17-284-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/252caa19934a/RPS-17-284-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/5df4e130a1ff/RPS-17-284-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/f774096932a9/RPS-17-284-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/2c61df802b76/RPS-17-284-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/a90698816605/RPS-17-284-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/4a0108827407/RPS-17-284-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/fc5448299a84/RPS-17-284-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/e0f989e255a0/RPS-17-284-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/252caa19934a/RPS-17-284-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/5df4e130a1ff/RPS-17-284-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/f774096932a9/RPS-17-284-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/2c61df802b76/RPS-17-284-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0280/9075020/a90698816605/RPS-17-284-g008.jpg

相似文献

1
Design and production of a novel chimeric human growth hormone superagonist fused to human Fc domain.一种与人类Fc结构域融合的新型嵌合人生长激素超级激动剂的设计与生产。
Res Pharm Sci. 2022 Apr 18;17(3):284-293. doi: 10.4103/1735-5362.343082. eCollection 2022 Jun.
2
Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.通过将Fc与促卵泡激素β亚基融合开发新型长效重组促卵泡激素激动剂并进行表征。
Hum Reprod. 2016 Jan;31(1):169-82. doi: 10.1093/humrep/dev295. Epub 2015 Nov 29.
3
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.美国临床内分泌医师协会和美国内分泌学会成人生长激素缺乏症管理指南以及儿科向成人保健过渡患者的指南。
Endocr Pract. 2019 Nov;25(11):1191-1232. doi: 10.4158/GL-2019-0405.
4
Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model.研发一种半衰期更长的重组人白细胞介素-15·可溶性白细胞介素-15 受体α/Fc 超激动剂,并在小鼠模型中评估其单独使用或与 PD-1 阻断联合使用的抗肿瘤活性。
Biomed Pharmacother. 2019 Apr;112:108677. doi: 10.1016/j.biopha.2019.108677. Epub 2019 Feb 21.
5
Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.受体结合对双功能转铁蛋白融合蛋白的血浆半衰期的影响。
Mol Pharm. 2011 Apr 4;8(2):457-65. doi: 10.1021/mp1003064. Epub 2011 Feb 22.
6
Long acting growth hormone (LAGH), an update.长效生长激素(LAGH),最新进展。
Front Pediatr. 2023 Sep 28;11:1254231. doi: 10.3389/fped.2023.1254231. eCollection 2023.
7
Production and enhanced biological activity of a novel GHRH analog, hGHRH with an N-terminal Pro-Pro extension.一种新型生长激素释放激素(GHRH)类似物,即具有N端脯氨酸-脯氨酸延伸的人GHRH的产生及其增强的生物学活性。
Protein Expr Purif. 2004 Apr;34(2):296-301. doi: 10.1016/j.pep.2003.11.012.
8
Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein.一种新型长效人生长激素:Fc融合蛋白的药代动力学、药效学及疗效
Mol Pharm. 2015 Oct 5;12(10):3759-65. doi: 10.1021/acs.molpharmaceut.5b00550. Epub 2015 Sep 21.
9
A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone.基于细胞的长效 Fc 融合重组人生长激素生物活性测定策略。
Molecules. 2019 Apr 9;24(7):1389. doi: 10.3390/molecules24071389.
10
Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.胃饥饿素和生长激素(GH)促分泌素可增强生长激素释放激素(GHRH)诱导的表达转染的GHRH和GH促分泌素受体的细胞中3',5'-环磷酸腺苷的生成。
Endocrinology. 2002 Dec;143(12):4570-82. doi: 10.1210/en.2002-220670.

引用本文的文献

1
Isolation, characterization, and expression of the (Caucasus viper) venom metalloprotease-like protein.高加索蝰蛇毒金属蛋白酶样蛋白的分离、特性鉴定及表达
Res Pharm Sci. 2025 Mar 31;20(2):207-217. doi: 10.4103/RPS.RPS_34_24. eCollection 2025 Apr.
2
Immunoinformatic approach to the design of a novel multi-epitope vaccine against fused to human IgG-Fc.一种针对与人类IgG-Fc融合的新型多表位疫苗设计的免疫信息学方法。
Res Pharm Sci. 2024 Dec 15;19(6):729-745. doi: 10.4103/RPS.RPS_145_24. eCollection 2024 Dec.
3
Growth hormone receptor agonists and antagonists: From protein expression and purification to long-acting formulations.

本文引用的文献

1
Evaluation of soluble expression of recombinant granulocyte macrophage stimulating factor (rGM-CSF) by three different strains.三种不同菌株对重组粒细胞巨噬细胞刺激因子(rGM-CSF)可溶性表达的评估。
Res Pharm Sci. 2020 Jul 3;15(3):218-225. doi: 10.4103/1735-5362.288424. eCollection 2020 Jun.
2
Long-Acting Human Growth Hormone Receptor Antagonists Produced in and Conjugated with Polyethylene Glycol.长效人重组生长激素受体拮抗剂的制备及聚乙二醇修饰
Bioconjug Chem. 2020 Jun 17;31(6):1651-1660. doi: 10.1021/acs.bioconjchem.0c00208. Epub 2020 Jun 4.
3
Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.
生长激素受体激动剂和拮抗剂:从蛋白表达和纯化到长效制剂。
Protein Sci. 2023 Sep;32(9):e4727. doi: 10.1002/pro.4727.
长效生长激素制剂 - 当前现状与未来考量。
J Clin Endocrinol Metab. 2020 Jun 1;105(6):e2121-33. doi: 10.1210/clinem/dgz149.
4
Targeting growth hormone function: strategies and therapeutic applications.靶向生长激素功能:策略与治疗应用。
Signal Transduct Target Ther. 2019 Feb 8;4:3. doi: 10.1038/s41392-019-0036-y. eCollection 2019.
5
Bioprocess and downstream optimization of recombinant human growth hormone in .重组人生长激素在……中的生物工艺及下游优化
Res Pharm Sci. 2018 Jun;13(3):222-238. doi: 10.4103/1735-5362.228953.
6
High level expression of recombinant human growth hormone in : crucial role of translation initiation region.重组人生长激素在 中的高水平表达:翻译起始区域的关键作用
Res Pharm Sci. 2017 Apr;12(2):168-175. doi: 10.4103/1735-5362.202462.
7
Twin arginine translocation system in secretory expression of recombinant human growth hormone.双精氨酸转运系统在重组人生长激素分泌表达中的作用
Res Pharm Sci. 2016 Dec;11(6):461-469. doi: 10.4103/1735-5362.194871.
8
Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery.单链 Fc 二聚体-人生长激素融合蛋白用于改善药物递送。
Biomaterials. 2017 Feb;117:24-31. doi: 10.1016/j.biomaterials.2016.11.051. Epub 2016 Nov 27.
9
Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?生长激素在体内的多种作用:它真的是促进生长的激素吗?
Clin Med Insights Endocrinol Diabetes. 2016 Oct 12;9:47-71. doi: 10.4137/CMED.S38201. eCollection 2016.
10
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.XTEN 蛋白聚合物延长生物活性分子的体内半衰期。
J Control Release. 2016 Oct 28;240:52-66. doi: 10.1016/j.jconrel.2015.10.038. Epub 2015 Oct 30.